Therefore c-Met gene amplification could bypass the inhibited EGFR phosphorylation kinase pathway and activate downstream signal transduction, thus facilitating the tumor cells proliferation and developing resistance to EGFR-TKI. The gene discussed is MET; the disease is neoplasm.